Classification of Gallbladder Carcinoma
Gallbladder carcinoma is classified using the TNM 2010 staging system (updated to TNM 8th edition in 2023), which provides anatomical staging based on depth of tumor invasion (T), regional lymph node involvement (N), and distant metastases (M). 1, 2
TNM Staging System for Gallbladder Cancer
The classification stratifies disease based on progressive anatomical invasion:
Primary Tumor (T) Classification
- Tis: Carcinoma in situ
- T1: Tumor invades lamina propria or muscular layer
- T1a: Tumor invades lamina propria only
- T1b: Tumor invades muscular layer
- T2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver
- T3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ (stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts)
- T4: Tumor invades main portal vein or hepatic artery, or invades two or more extrahepatic organs or structures 1
Regional Lymph Nodes (N) Classification
- NX: Regional lymph nodes cannot be assessed
- N0: No regional lymph node metastasis
- N1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein
- N2: Metastases to periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes 1
Histopathological Classification
According to the World Health Organization classification, approximately 95% of gallbladder carcinomas are adenocarcinomas. 3, 4 The histological subtypes include:
- Adenocarcinoma (most common, ~95%)
- Graded 1-4 based on percentage of glandular tissue
- Includes papillary, clear cell, and intestinal-type variants
- Undifferentiated carcinoma (small cell, pleomorphic, spindle cell types) 5
- Squamous cell carcinoma
- Adenosquamous carcinoma
Clinical Staging Considerations
The staging must be performed according to the UICC TNM 8th edition (2023 update), which is specific for gallbladder cancer and differs from staging systems for cholangiocarcinoma. 2, 6
Key Staging Workup Components
Complete staging requires 1, 2:
- Imaging: MRI (reference standard for local extension and hepatic metastases), thoraco-abdomino-pelvic CT (for lymph node and metastatic assessment)
- Laboratory: Blood counts, liver function tests, tumor markers (CA 19-9, CEA)
- Endoscopic evaluation: ERCP or PTC for biliary assessment
- Advanced imaging: Consider FDG-PET for detecting occult metastases (not for primary diagnosis)
- Staging laparoscopy: May detect peritoneal dissemination in 20-28.6% of cases not found on imaging 7
Important Clinical Distinctions
The T1a versus T1b distinction is critical for treatment decisions: Patients with T1a tumors (lamina propria invasion only) who had intact gallbladder removal do not benefit from re-resection and should be observed only. However, T1b or greater disease requires radical re-resection after complete staging including laparoscopy. 1
Common Pitfalls
- Do not confuse gallbladder cancer staging with cholangiocarcinoma staging—they use different TNM systems despite both being biliary tract cancers 2, 6
- Avoid laparoscopic cholecystectomy in patients with suspected gallbladder carcinoma on preoperative imaging; proceed directly to open extended cholecystectomy if resectable 8
- Port-site excision is mandatory if gallbladder cancer is discovered on pathology after laparoscopic removal 8
The classification system has evolved from TNM 2002 to TNM 2010 to the current 8th edition (2023), with refinements in T-category definitions and transition from nodal location to nodal burden assessment, though overall prognostic discrimination remains modest with concordance indices around 0.66. 9